Selected article for: "clinical epidemiology and present study"
Author: Jafari, Ameneh; Rezaei-Tavirani, Mostafa; Karami, Samira; Yazdani, Mohsen; Zali, Hakimeh; Jafari, Zahra
Title: Cancer Care Management During the COVID-19 Pandemic
  • Cord-id: isim6a5o
  • Document date: 2020_9_23
    • ID: isim6a5o
    Snippet: New cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing around the world. Currently, health care services are mainly focused on responding to and controlling the unique challenges of the coronavirus disease 2019 (COVID-19) pandemic. These changes, along with the higher susceptibility of patients with cancer to infections, have profound effects on other critical aspects of care and pose a serious challenge for the treatment of
    Document: New cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing around the world. Currently, health care services are mainly focused on responding to and controlling the unique challenges of the coronavirus disease 2019 (COVID-19) pandemic. These changes, along with the higher susceptibility of patients with cancer to infections, have profound effects on other critical aspects of care and pose a serious challenge for the treatment of such patients. During the COVID-19 pandemic, it is important to provide strategies for managing the treatment of patients with cancer to limit COVID-19-associated risks at this difficult time. The present study set out to summarize the latest research on epidemiology, pathogenesis, and clinical features of COVID-19. We also address some of the current challenges associated with the management of patients with cancer during the COVID-19 pandemic and provide practical guidance to clinically deal with these challenges.

    Search related documents:
    Co phrase search for related documents
    • abroad travel and acute sars cov respiratory syndrome coronavirus: 1
    • acceptable safety profile and active cancer: 1
    • acceptable safety profile and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • acceptable safety profile and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6
    • access journal and accumulate evidence: 1
    • access journal and acute respiratory syndrome: 1
    • access journal and acute sars cov respiratory syndrome coronavirus: 1
    • accessory protein and acute ards respiratory distress syndrome: 1
    • accessory protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accessory protein and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accumulate evidence and acute respiratory syndrome: 1
    • active anticancer therapy and acute respiratory syndrome: 1, 2
    • active cancer and acute ards respiratory distress syndrome: 1, 2
    • active cancer and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active cancer patient and acute respiratory syndrome: 1